These genetic disorders result from reduced levels of gonadotropin and sex steroids in the absence of anatomical or functional abnormalities of the hypothalamic–pituitary–gonadal axis.

Gonadorelin, a synthetic analog of the gonadotropin-releasing hormone (GnRH), has garnered attention for its intriguing ...